RNA extraction

NEW YORK (GenomeWeb News) – ZyGem today said that it has entered into an agreement with Quanta BioSciences to incorporate its enzymatic RNA-extraction technology into Quanta's quantitative PCR reagent kits.

ZyGem said today that it has signed an OEM agreement with Saudi Diagnostics, which will market ZyGem's DNA and RNA extraction kits for a variety of research applications.

GSK gains certain rights to Response Genetics' PCR analysis technology and diagnostic expertise to assess BRAF mutations in human tumor samples.

The company already offers many of these services to customers in North America and Europe through Gaithersburg, Md.-based subsidiary Gene Logic.

ZyGem's method, available in a commercial kit, can prepare samples in under 20 minutes, or up to ten times faster than existing RNA extraction products; while Genomic Health's method can access the entire transcriptome from formalin-fixed, paraffin-embedded tissues for downstream analyses.

Researchers have treated an X-linked genetic disease affecting three babies in utero, Stat News reports.

The Associated Press reports that the US Centers for Disease Control and Prevention is beefing up sequencing as a tool to investigate foodborne illnesses.

Researchers have sequenced samples from ancient toilets to study past eating habits and health, NPR reports.

In Nature this week: ash dieback disease fungal genome, and more.